Thicken your knowledge about hypertrophic cardiomyopathy with Rahul as he interviews the superb Dr. Andris Ellims, head of the Alfred HCM clinic. This episode includes a brief update of HCM diagnosis and genetics before exploring contemporary management strategies for HCM.

As you might be aware, mavacamten (a cardiac myosin inhibitor) has just been approved in Australia for the treatment of obstructive HCM. Now is a great time to get familiar with the data behind the drug and get some practical tips from one of Australia's best on how to use it in your practice.